- Home
- BALY vs CRMD Comparison
BALY vs CRMD Comparison
Compare BALY & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BALY | CRMD |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | United States |
| Employees | 11700 | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 711.1M | 590.7M |
| IPO Year | 2019 | 2009 |
Fundamental Metrics
Financial Performance| Metric | BALY | CRMD |
|---|---|---|
| Price | $13.51 | $5.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $9.67 | ★ $15.33 |
| AVG Volume (30 Days) | 76.1K | ★ 1.1M |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.37 | ★ 780.00 |
| EPS | N/A | ★ 0.72 |
| Revenue | ★ $2,436,189,000.00 | $311,709,000.00 |
| Revenue This Year | $19.09 | $8.13 |
| Revenue Next Year | $8.08 | N/A |
| P/E Ratio | ★ N/A | $10.54 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $8.44 | $6.13 |
| 52 Week High | $19.60 | $13.02 |
Technical Indicators
Market Signals| Indicator | BALY | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 25.16 |
| Support Level | $13.38 | N/A |
| Resistance Level | $14.20 | $8.81 |
| Average True Range (ATR) | 0.57 | 0.46 |
| MACD | -0.13 | -0.09 |
| Stochastic Oscillator | 52.04 | 0.74 |
Price Performance
Historical ComparisonAbout BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, entertainment, and technology company operating across casino, interactive, and lottery markets. It provides physical and interactive gaming experiences, including casino gaming, iGaming, sportsbook, online bingo, free-to-play games, and technology-driven lottery solutions. The company's segments include Casinos & Resorts, which generates maximum revenue and operates casino and resort properties, a horse racetrack, and a golf course; Bally's Intralot B2B, which provides lottery and technology services; Bally's Intralot B2C, which includes interactive gaming and lottery operations, including a UK casino; and North America Interactive, which includes sports betting and iGaming operations in the United States and Canada.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.